Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
Regulator First, Rules Later: Bill C-34 Debate Shows the Government Wants a Digital Safety Commission Before It Figures Out What It Will Do 
Making the Case Against Its Own Bill: What the Government’s Bill C-34 Charter Statement Reveals About the Constitutional Vulnerability of the Social Media Ban 
“Position Has Not Changed”: The Canadian Government Reaffirms That Antisemitism Includes Anti-Zionism 
The Law Bytes Podcast, Episode 279: My Keynote on Digital Sovereignty: Control, Choice, and Connection 
The What, Me Worry? Consultation: Media Quietly Tells Government It Wants Even More Funding With Little Concern for Independence Risks
